TRENDING :  Market Movers  |  Top 50   FDX (0%)    SPY (0%)    AMZN (0%)    VXXB (0%)    WYNN (0%)    XLF (0%)    XLU (0%)    XRX (0%)    ZUO (0%)    LVS (0%)    MCD (0%)    NFLX (0%)    NRG (0%)    NXST (0%)    PBR (0%)    PEI (0%)    POST (0%)    PYPL (0%)    QQQ (0%)    ROKU (0%)    SBUX (0%)    SCIF (0%)    SLNO (0%)    SQ (0%)    TAC (0%)

 ARRY - Array BioPharma Inc.

$22.47 [-0.02][-0.09%]

Next Earnings

5/8/2019

BMO

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

1


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $30.00
Low $30.00
Average $30.00
Current $22.47

CompanyAnalyst NamePT ActionActionRatingTargetDate
Cantor FitzgeraldMara GoldsteinAnnouncesInitiates Coverage OnStrong Buy$30.0001/15/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $ARRY

TRENDING ARTICLES



Why Array BioPharma Stock Soared 22.9% in February

03/06/19
What happened Shares 160 of Array BioPharma NASDAQ ARRY gained 22 9 last month according to data from S amp P Global Market Intelligence The stock is up 63 in 2019 through March 5 The Boulder Colorado based biotech is focused on developing targeted small molecule

Watch Out: 5 Stocks Seeing Insider Selling Right Now

02/27/19
Insider transactions can provide a valuable glimpse into how corporate insiders really view a company As the famous saying goes Actions speak louder than words And the advantage here is that insiders such as executives and directors may well have a greater insight into the company